Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
The latest update is out from Exosens ( (FR:EXENS) ).
Exosens, a specialist in mission-critical amplification, detection and imaging technologies, is expanding its role in the defense and autonomous systems market with a focus on compact thermal cameras and cooled infrared solutions. The company targets next-generation drone and counter-drone platforms, leveraging its non-ITAR positioning, long-standing R&D investments and global industrial footprint to support leading defense OEMs and autonomous systems developers.
The group plans to triple its thermal camera production capacity in 2026 to meet accelerating global demand for drone and counter-drone applications, following an earlier move to double output of cooled infrared cameras for long-range surveillance. By scaling its agile supply chain and manufacturing capabilities, Exosens aims to speed integration and time-to-market for its customers, strengthen its position in fast-growing defense markets and capture structural growth in autonomous military systems.
The most recent analyst rating on (FR:EXENS) stock is a Hold
with a EUR60.00 price target.
To see the full list of analyst forecasts on Exosens stock,
see the FR:EXENS Stock Forecast page.
More about Exosens
Exosens is a high-technology optoelectronics group specializing in mission-critical detection, photodetection and imaging solutions, including digital cameras and ion, electron, neutron and gamma detectors. With more than 85 years of experience, 13 production and R&D sites across Europe and North America, and over 2,000 employees, it serves demanding defense and industrial markets and is listed on Euronext Paris in the Euronext Tech Leaders segment.
Average Trading Volume: 88,894
Technical Sentiment Signal: Strong Buy
Current Market Cap: €3.16B
See more insights into EXENS stock on TipRanks’ Stock Analysis page.

